Cargando…

Antitumor Activities of a Novel 9‐Aminoanthracycline (SM‐5887) against Mouse Experimental Tumors and Human Tumor Xenografts

The antitumor effects of SM‐5887, a totally synthetic 9‐aminoanthracycline derivative, were evaluated in six murinc experimental tumor systems (P38S, Ehrlich carcinoma, sarcoma 180, Lewis lung carcinoma, B16 melanoma and colon 38) and nine human tumor‐nude mouse systems (one breast cancer, two lung...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morisada, Shinya, Yanagi, Yoshikazu, Noguchi, Toshihiro, Kashiwazaki, Yasuo, Fukui, Masaru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1989
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917680/ https://www.ncbi.nlm.nih.gov/pubmed/2496061 http://dx.doi.org/10.1111/j.1349-7006.1989.tb02247.x

Ejemplares similares

Toxicological Aspects of a Novel 9‐Aminoanthracycline, SM‐5887
por: Morisada, Shinya, et al.
Publicado: (1989)

Tumor‐selective Distribution of an Active Metabolite of the 9‐Aminoanthracycline Amrubicin
por: Noguchi, Toshihiro, et al.
Publicado: (1998)

Cytotoxicity of Amrubicin, a Novel 9‐Aminoanthracycline, and Its Active Metabolite Amrubicinol on Human Tumor Cells
por: Yamaoka, Takashi, et al.
Publicado: (1998)

In vivo Efficacy and Tumor‐selective Metabolism of Amrubicin to Its Active Metabolite
por: Noguchi, Toshihiro, et al.
Publicado: (1998)

Uptake and Intracellular Distribution of Amrubicin, a Novel 9‐Amino‐anthracycline, and Its Active Metabolite Amrubicinol in P388 Murine Leukemia Cells
por: Yamaoka, Takashi, et al.
Publicado: (1999)

Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor model
por: Li, Zhanrong, et al.
Publicado: (2012)

Antitumor effect of antitissue factor antibody‐MMAE conjugate in human pancreatic tumor xenografts
por: Koga, Yoshikatsu, et al.
Publicado: (2015)

Favorable Antitumor Activity of Citrus microcarpa B. on Human Colon Adenocarcinoma Tumor Xenografted in Immunosupressed Mice
por: Ples, Michael, et al.
Publicado: (2023)

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts
por: Chamorro, Sonia, et al.
Publicado: (2014)

Antitumor Effects of Delta (9)-Tetrahydrocannabinol and Cannabinol on Cholangiocarcinoma Cells and Xenograft Mouse Models
por: Leelawat, Surang, et al.
Publicado: (2022)

Antitumor Activity of TAK-285, an Investigational, Non-Pgp Substrate HER2/EGFR Kinase Inhibitor, in Cultured Tumor Cells, Mouse and Rat Xenograft Tumors, and in an HER2-Positive Brain Metastasis Model
por: Nakayama, Akiko, et al.
Publicado: (2013)

In Silico and In Vivo Studies of a Tumor-Penetrating and Interfering Peptide with Antitumoral Effect on Xenograft Models of Breast Cancer
por: Marin, Gustavo H., et al.
Publicado: (2023)

Fucoxanthin administration delays occurrence of tumors in xenograft mice by colonospheres, with an anti-tumor predictor of glycine
por: Terasaki, Masaru, et al.
Publicado: (2019)

The B-Raf Status of Tumor Cells May Be a Significant Determinant of Both Antitumor and Anti-Angiogenic Effects of Pazopanib in Xenograft Tumor Models
por: Gril, Brunilde, et al.
Publicado: (2011)

Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9(+) tumors
por: Santamaria, Silvia, et al.
Publicado: (2022)

A New Antitumor Agent Amrubicin Induces Cell Growth Inhibition by Stabilizing Topoisomerase II‐DNA Complex
por: Hanada, Mitsuharu, et al.
Publicado: (1998)

Tumor Vasculature-Targeted Recombinant Mutated Human TNF-α Enhanced the Antitumor Activity of Doxorubicin by Increasing Tumor Vessel Permeability in Mouse Xenograft Models
por: Jiang, Changli, et al.
Publicado: (2014)

Endostatin enhances antitumor effect of tumor antigen-pulsed dendritic cell therapy in mouse xenograft model of lung carcinoma
por: Liang, Jing, et al.
Publicado: (2016)

Defucosylated Mouse–Dog Chimeric Anti-EGFR Antibody Exerts Antitumor Activities in Mouse Xenograft Models of Canine Tumors
por: Li, Guanjie, et al.
Publicado: (2021)

Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors
por: Schäfer, Simon, et al.
Publicado: (2012)

Applications of patient-derived tumor xenograft models and tumor organoids
por: Yoshida, Go J.
Publicado: (2020)

Epidermal Growth Factor Receptor‐mediated Selective Cytotoxicity of Antitumor Agents toward Human Xenografts and Murine Syngeneic Solid Tumors
por: Amagase, Harunobu, et al.
Publicado: (1989)

Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer
por: Lu, Jun, et al.
Publicado: (2015)

Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts
por: IWAI, TOSHIKI, et al.
Publicado: (2011)

FK317, a Novel Substituted Dihydrobenzoxazine, Exhibits Potent Antitumor Activity against Human Tumor Xenografts in Nude Mice
por: Naoe, Yoshinori, et al.
Publicado: (1998)

Plocabulin, a novel tubulin inhibitor, has potent antitumor activity in patient-derived xenograft models of gastrointestinal stromal tumors
por: Wang, Yannick, et al.
Publicado: (2020)

In vivo Antitumor Mechanism of Natural Human Tumor Necrosis Factor Involving a T Cell‐mediated Immunological Route
por: Asami, Tetsuya, et al.
Publicado: (1989)

Enhanced Antitumor Efficacy of a Combination of CPT‐11, a New Derivative of Camptothecin, and Cisplatin against Human Lung Tumor Xenografts
por: Kudoh, Shinzoh, et al.
Publicado: (1993)

A Liposomal Gemcitabine, FF-10832, Improves Plasma Stability, Tumor Targeting, and Antitumor Efficacy of Gemcitabine in Pancreatic Cancer Xenograft Models
por: Matsumoto, Takeshi, et al.
Publicado: (2021)

Defucosylated mouse-dog chimeric anti-HER2 monoclonal antibody exerts antitumor activities in mouse xenograft models of canine tumors
por: Suzuki, Hiroyuki, et al.
Publicado: (2022)

Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors()
por: Bondarenko, Gennadiy, et al.
Publicado: (2015)

Enhancement of Tumor Radio‐response by Irinotecan in Human Lung Tumor Xenografts
por: Tamura, Kenji, et al.
Publicado: (1997)

Flaviviruses in AntiTumor Therapy
por: Nazarenko, Alina S., et al.
Publicado: (2023)

Antitumor effect of Kanglaite® injection in human pancreatic cancer xenografts
por: Liu, Ying, et al.
Publicado: (2014)

Modeling Lung Carcinoids with Zebrafish Tumor Xenograft
por: Carra, Silvia, et al.
Publicado: (2022)

IL-9 Exerts Antitumor Effects in Colon Cancer and Transforms the Tumor Microenvironment In Vivo
por: Wang, Jin, et al.
Publicado: (2019)

Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity
por: Sun, Xian, et al.
Publicado: (2023)

Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse model
por: Chang, De-Kuan, et al.
Publicado: (2015)

Spontaneous mouse lymphoma in patient-derived tumor xenografts: The importance of systematic analysis of xenografted human tumor tissues in preclinical efficacy trials
por: Chateau-Joubert, Sophie, et al.
Publicado: (2021)

The effect of chemotherapeutic agents on tumor vasculature in subcutaneous and orthotopic human tumor xenografts
por: Fung, Andrea S, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_snm8ivt9jnahcft8ett42iaqfd